CDK2/4/6-IN-1 is a CDK2/4/6 inhibitor with IC50 values of 2.5, 23.7, and 44.3 nM against CDK2, CDK4, and CDK6, respectively; it is used in cancer research; it serves as a click chemistry reagent containing an alkyne group that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules.